Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use

Journal of Biomedical Nanotechnology

Volumn 9, Issue 4, 2013, Pages 564-576

  Aggarwal, Nidhi ^a   Goindi, Shishu ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Antifungal; Bioavailability; Dermatokinetics; Dermatophytosis; Skin Permeation

Indexed keywords

ANTI-FUNGAL; BIOAVAILABILITY; DERMATOKINETICS; DERMATOPHYTOSIS; SKIN PERMEATION;

BIOCHEMISTRY; FUNGI; MICROEMULSIONS; OPTIMIZATION;

NANOPARTICLES;

GRISEOFULVIN; SOLID LIPID NANOPARTICLE;

ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTHRODERMA GYPSEUM; ARTICLE; CONTROLLED DRUG RELEASE; DRUG STABILITY; EX VIVO STUDY; FLUORESCENCE MICROSCOPY; FUNGAL STRAIN; GUINEA PIG; IN VIVO STUDY; MICROSPORUM CANIS; MICROSPORUM CANIS INFECTION; MOUSE; NONHUMAN; SKIN PENETRATION; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIFUNGAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; FUNGI; GRISEOFULVIN; GUINEA PIGS; LIPIDS; MALE; MICE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, FLUORESCENCE; MYCOSES; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; RHODAMINE 123; SKIN; SKIN ABSORPTION; SOLUBILITY;

EID: 84876517076     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1569     Document Type: Article

References (31)

1. M. Nino, G. Calabrò, and P. Santoianni, Topical delivery of active principles: The field of dermatological research. Dermatology Online Journal 1, 1 (2010).
2. P. L. Honeywell-Nguyen and J. A. Bouwstra, Vesicles as a tool for transdermal and dermal delivery. Drug Discov. Today: Technol. 2, 67 (2005).
3. A. K. Shah, A. A. Date, M. D. Joshi, and V. B. Patravale, Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int. J. Pharm. 345, 163 (2007).
4. S. D. Mandawgade and V. B. Patravale, Development of SLNs from natural lipids: Application to topical delivery of tretinoin. Int. J. Pharm. 363, 132 (2008).
5. P. A. Grabnar, J. Kristl, S. Pecar, J. Strancar, and M. Sentjurc, The effect of lipophilicity of spin-labeled compounds on their distribution in solid lipid nanoparticle dispersions studied by electron paramagnetic resonance. J. Pharm. Sci. 92, 58 (2003).
6. Q. Lv, A. Yu, Y. Xi, H. Li, Z. Song, J. Cui, F. Cao, and G. Zhai, Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int. J. Pharm. 372, 191 (2009).
7. M. E. Nimni, D. Ertl, and R. A. Oakes, Distribution of griseofulvin in the rat: Comparison of the oral and topical route of administration. J. Pharm. Pharmacol. 42, 729 (1990).
8. R. Aly, C. I. Bayles, R. A. Oakes, D. J. Bibel, and H. I. Maibach, Topical griseofulvin in the treatment of dermatophytoses. Clin. Exp. Dermatol. 19, 43 (1994).
9. M. Fujii, M. Bouno, S. Fujita, M. Yoshida, Y. Watanabe, and M. Matsumoto, Preparation of griseofulvin for topical application using N-methyl-2- pyrrolidone. Biol. Pharm. Bull. 23, 1341 (2000).
10. E. Pierri and K. Avgoustakis, Poly(lactide)-poly(ethylene glycol) micelles as a carrier for griseofulvin. J. Biomed. Mater. Res. A 75, 639 (2005).
11. S. Gupta, D. Ahirwar, N. K. Sharma, and D. Jhade, Proniosomal gel as a carrier for improved transdermal delivery of griseofulvin: Preparation and in-vitro characterization. Res. J. Pharma. Dos. Tech. 1, 33 (2009).
12. E. Peira, M. Gallarate, R. Spagnolo, D. Chirio, and M. Trotta, Thermogelling microemulsions for topical delivery of griseofulvin. J. Drug Del. Sci. Tech. 21, 1 (2011).
13. J. S. Mulla and I. M. Khaziz, Influence of process variables on particle size of solid lipid nanoparticles. Ind. J. Novel Drug Del. 1, 47 (2009).
14. A. Azeem, S. Talegaonkar, L. M. Negi, F. J. Ahmad, R. K. Khar, and Z. Iqbal, Oil based nanocarrier system for transdermal delivery of ropinirole: A mechanistic, pharmacokinetic and biochemical investigation. Int. J. Pharm. 422, 436 (2012).
15. N. Aggarwal, S. Goindi, and S. D. Mehta, Preparation and evaluation of dermal delivery system of griseofulvin containing Vitamin E-TPGS as penetration enhancer. AAPS Pharm. Sci. Tech. 13, 67 (2012).
16. B. Wei, D. Liang, and R. B. Theodore, Development and validation of a HPLC method to determine griseofulvin in rat plasma: Application to pharmacokinetic studies. Anal. Chem. Insights 3, 103 (2008).
17. B. Kim, H. Doh, T. N. Le, W. Cho, C. Yong, and H. Choi, Ketorolac amide prodrugs for transdermal delivery: Stability and in vitro rat skin permeation studies. Int. J. Pharm. 293, 193 (2005).
18. M. E. S. Barros, D. A. Santos, and J. S. Hamdan, Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). J. Med. Microbiol. 56, 514 (2007).
19. C. R. Araujo, K. C. Miranda, O. F. L. Fernandes, A. J. Soares, and M. R. R. Silva, In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method. Rev. Inst. Med. Trop. S. Paulo. 51, 9 (2009).
20. M. A. Ghannoum, M. A. Hossain, L. Long, S. Mohamed, G. Reyes, and P. K. Mukherjee, Evaluation of antifungal efficacy in an optimized animal model of Trichophyton mentagrophytes- Dermatophytosis. J. Chemother. 16, 139 (2004).
21. H. Alkhayat, N. Al-Sulaili, E. O'Brien, C. McCuaig, and K. Watters, The PAS stain for routine diagnosis of onychomycosis. Bahrain Med. Bull. 31, 1 (2009).
22. G. Abdelbary and R. H. Fahmy, Diazepam-loaded solid lipid nanoparticles: Design and characterization. AAPS Pharm. Sci. Tech. 10, 211 (2009).
23. R. Paliwal, S. Rai, B. Vaidya, K. Khatri, A. K. Goyal, N. Mishra, A. Mehta, and S. P. Vyas, Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomed.: Nanotech. Biol. Med. 5, 184 (2009).
24. S. Kheradmandnia, E. Vasheghani-Farahani, M. Nosrati, and F. Atyabi, Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Nanomed.: Nanotech. Biol. Med. 6, 753 (2010).
25. V. Venkateshwarlu and K. Manjunath, Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Rel. 95, 627 (2004).
26. H. B. Chen, X. L. Chang, X. L. Yang, D. R. Du, W. Liu, J. Liu, T. Weng, Y. J. Yang, and H. B. Xu, Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control Rel. 110, 296 (2006).
27. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu, and X. Yang, Isotretinoinloaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 328, 191 (2008).
28. K. Bhaskar, M. C. Krishna, M. Lingam, M. S. Jagan, V. Venkateswarlu, R. Y. Madhusudan, K. Bhaskar, J. Anbu, and V. Ravichandran, Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: In vitro and in vivo characteristics. Drug Dev. Ind. Pharm. 35, 98 (2008).
29. V. Sanna, G. Caria, and A. Mariani, Effect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of Econazole nitrate. Powder Tech. 201, 32 (2010).
30. P. Desai, R. R. Patlolla, and M. Singh, Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol. Membr. Biol. 27, 247 (2010).
31. S. Küchler, W. Herrmann, G. Panek-Minkin, T. Blaschke, C. Zoschke, K. D. Kramer, R. Bittl, and M. Schäfer-Korting, SLN for topical application in skin diseases-Characterization of drug-carrier and carrier-target interactions. Int. J. Pharm. 390, 225 (2010).